Brickell Biotech, Inc. (BBI) has 28 open-market insider trades by 20 insiders since 2006. The most active filer is Mark J. Wattles, 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Offshore Lp Icahn | 10% | — | 1 | $3.7M | 2010-03-30 |
| Onshore Lp Icahn | 10% | — | 1 | $3.7M | 2010-03-30 |
| Bank Ag\ Deutsche | 10% | — | 2 | $3.5M | 2007-05-16 |
| James W. Keyes | Chairman | — | 1 | $3.0M | 2009-03-13 |
| Nicholas P. Shepherd | SEVP and COO | — | 2 | $1.3M | 2007-08-16 |
| John F. Antioco | Chairman | — | 1 | $1.0M | 2007-07-02 |
| Mark J. Wattles | 10% | — | 4 | $436K | 2010-07-26 |
| Michael Zimmerman | Dir10% | — | 1 | $250K | 2009-12-31 |
| Jules Haimovitz | Dir | — | 1 | $149K | 2010-07-01 |
| Reginald L. Hardy | Chairman | — | 1 | $133K | 2021-12-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David R. McAvoy | General Counsel and CCO | Buy | $12K | 2021-07-23 |
| Reginald L. Hardy | Chairman | Buy | $133K | 2021-07-23 |
| Deepak Chadha | Chief Research & Dev. Officer | Buy | $13K | 2021-05-18 |
| Andrew D. Sklawer | Secretary | Buy | $12K | 2021-05-17 |
| David R. McAvoy | General Counsel and CCO | Buy | $21K | 2021-05-17 |
| Robert Busard Brown | CEO | Buy | $118K |
Companies that share insiders with BBI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-03-15 |
| David R. McAvoy | General Counsel and CCO | Buy | $19K | 2020-09-18 |
| Dennison T. Veru | Director | Buy | $24K | 2020-09-15 |
| Mark J. Wattles | 10% | Sell | $192K | 2010-07-22 |
| Capital Management Llc Wattles | 10% | Sell | $70K | 2010-07-19 |
| Mark J. Wattles | 10% | Sell | $38K | 2010-07-15 |
| Mark J. Wattles | 10% | Sell | $43K | 2010-07-08 |
| Mark J. Wattles | 10% | Sell | $163K | 2010-07-02 |
| Onshore Lp Icahn | 10% | Sell | $3.7M | 2010-03-26 |
| Michael Zimmerman | Director & 10% | Sell | $250K | 2009-12-29 |